Teva Pharmaceutical Industries Ltd. - Company & Market Research Reports

Teva Pharmaceuticals develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. The company has a portfolio of more than 1,000 molecules, producing approximately 64 billion tablets and capsules a year at 66 manufacturing facilities. It currently ranks among the 10 top pharmaceutical companies in the world and is active in 60 countries. Founded in 1901, and based in Israel, Teva employs approximately 58,000 people around the world.


Remicade Biosimilar Market: By Type, By Technology, By Service, By Application, By Region - Forecast 2016-2021 - Product Thumbnail Image

Remicade Biosimilar Market: By Type, By Technology, By Service, By Application, By Region - Forecast 2016-2021

  • Report
  • 146 Pages
From
Global Biosimilar Market by Classes (Insulin, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte-Colony Stimulating Factor (G-CSF), Monoclonal Antibody (mAb) and Interferon (IFN) & Markets (Developed & Emerging) - Industry Outlook 2020 - Product Thumbnail Image

Global Biosimilar Market by Classes (Insulin, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte-Colony Stimulating Factor (G-CSF), Monoclonal Antibody (mAb) and Interferon (IFN) & Markets (Developed & Emerging) - Industry Outlook 2020

  • Report
  • 112 Pages
From
Biogenerics: The World Market for Biosimilars - Product Thumbnail Image

Biogenerics: The World Market for Biosimilars

  • Report
  • 153 Pages
From
Generic Drug Opportunity Assessment - Fingolimod (Gilenya) - Product Thumbnail Image

Generic Drug Opportunity Assessment - Fingolimod (Gilenya)

  • Report
From
Buccal Drug Delivery Systems: Opportunities And Challenges In Buccal, Sublingual Films, Tablets & Sprays  - Detailed Analysis On Technologies And Pipeline Development - Product Thumbnail Image

Buccal Drug Delivery Systems: Opportunities And Challenges In Buccal, Sublingual Films, Tablets & Sprays - Detailed Analysis On Technologies And Pipeline Development

  • Report
  • 70 Pages
From
CIPLA, Para IV Upside To Continue: Its Lexapro After Zyprexa - Product Thumbnail Image

CIPLA, Para IV Upside To Continue: Its Lexapro After Zyprexa

  • Report
From
Global Hepatocellular Carcinoma Drug Sales (Nexavar & Miripla), Pipeline Analysis and Global Market Forecast 2022 - Product Thumbnail Image

Global Hepatocellular Carcinoma Drug Sales (Nexavar & Miripla), Pipeline Analysis and Global Market Forecast 2022

  • Report
  • 70 Pages
From
Bulk Paclitaxel - Global Strategic Business Report - Product Thumbnail Image

Bulk Paclitaxel - Global Strategic Business Report

  • Report
  • 232 Pages
From
Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market Analysis By Product (Nanoparticles and Embolization Particles), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market Analysis By Product (Nanoparticles and Embolization Particles), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2014 - 2025

  • Report
  • 92 Pages
From
Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets - Product Thumbnail Image

Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets

  • Report
  • 126 Pages
From
Generic and Biosimilar Pharmaceuticals (GLOBAL) - Industry Report - Product Thumbnail Image

Generic and Biosimilar Pharmaceuticals (GLOBAL) - Industry Report

  • Report
  • 1410 Pages
From
The World Market for Transdermal Drug Delivery - Product Thumbnail Image

The World Market for Transdermal Drug Delivery

  • Report
  • 100 Pages
From
Spain Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices - Product Thumbnail Image

Spain Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • Report
  • 116 Pages
From
Russia Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices - Product Thumbnail Image

Russia Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • Report
  • 96 Pages
From
The 2018-2023 World Outlook for Over-the-counter (OTC) Generic Drugs - Product Thumbnail Image

The 2018-2023 World Outlook for Over-the-counter (OTC) Generic Drugs

  • Report
  • 295 Pages
U.S. Specialty Injectable Generics Market Analysis By Therapeutic Use (Oncology, Cardiovascular, Central Nervous System, Infectious Diseases, Autoimmune Disorders), And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

U.S. Specialty Injectable Generics Market Analysis By Therapeutic Use (Oncology, Cardiovascular, Central Nervous System, Infectious Diseases, Autoimmune Disorders), And Segment Forecasts, 2014 - 2025

  • Report
  • 76 Pages
From
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 90 Pages
From
Dry Powder Inhaler Devices Market: By Type; By Therapeutics & By Region - Forecast 2016-2022 - Product Thumbnail Image

Dry Powder Inhaler Devices Market: By Type; By Therapeutics & By Region - Forecast 2016-2022

  • Report
  • 176 Pages
From
COPD and Asthma Devices Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) - Global Opportunity Analysis and Industry Forecasts, 2015 - 2022 - Product Thumbnail Image

COPD and Asthma Devices Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) - Global Opportunity Analysis and Industry Forecasts, 2015 - 2022

  • Report
  • 158 Pages
From
Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2017 - Product Thumbnail Image

Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2017

  • Report
  • 246 Pages
From
Loading Indicator
adroll